Correlations Between Serum Uric Acid Level and Disease Activity, Intrathecal Inflammation Reactivity in Patients with Multiple Sclerosis
Cai-yan Liu1, Yan Xu1, Li-ying Cui1*, Bin Peng1, Li-zhen Zhong2, Xing-wang Chen3, and Jian-ming Wang1
1Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
2Department of Neurology, Dalian Central Hospital, Dalian 116033, China
3Department of Neurology, Shandong Traffic Hospital, Jinan 250031, China
Cai-yan Liu, Yan Xu, Li-ying Cui*, Bin Peng, Li-zhen Zhong, Xing-wang Chen, and Jian-ming Wang. Correlations Between Serum Uric Acid Level and Disease Activity, Intrathecal Inflammation Reactivity in Patients with Multiple Sclerosis[J].Chinese Medical Sciences Journal, 2012, 27(2): 88-91.
Scott GS, Hooper DC. The role of uric acid in protection against peroxynitrite-mediated pathology. Med Hypoth- eses 2001; 56:95-100.
Hooper DC, Bagasra O, Marini JC, et al. Prevention of experimental allergic encephalo-myelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 1997; 94: 2528-33.
Toncev G, Milicic B, Toncev S, et al. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood–brain barrier dysfunction. Eur J Neurol 2002; 9:221-6.
Rentzos M, Nikolaou C, Anagnostouli M, et al. Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg 2006; 108:527-31.
Knapp CM, Constantinescu CS, Tan JH, et al. Serum uric acid levels in optic neuritis. Mult Scler 2004; 10:278-80.
Peng F, Zhang B, Zhong X, et al. Serum uric acid levels of patients with multiple sclerosis and other neurological diseases. Mult Scler 2008; 14:188-96.
Mostert JP, Ramsaransing GSM, Heersema DJ, et al. Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses. J Neurol Sci 2005; 231:41-4.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005; 58:840-6.
Sotgiu S, Pugliatti M, Sanna A, et al. Serum uric acid and multiple sclerosis. Neurol Sci 2002; 23:183-8.
Drulović J, Dujmović I, Stojsavljević N, et al. Uric acid levels in sera from patients with multiple sclerosis. J Neurol 2001; 248:121-6.
Liu B, Shen Y, Xiao K, et al. Serum uric acid levels in patients with multiple sclerosis: a meta-analysis. Neurol Res 2012; 34:163-71.
Guerrero AL, Gutiérrez F, Iglesias F, et al. Serum uric acid levels in multiple sclerosis patients inversely correlate with disability. Neurol Sci 2011; 32:347-50.
Raine CS. Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann Neurol 1994; 36:S61-S72.